Persistent serpentine supravenous hyperpigmented eruption associated with docetaxel

Journal of the European Academy of Dermatology and Venereology

Volumn 19, Issue 3, 2005, Pages 345-347

  Aydogan, I ^a   Kavak, A ^a   Parlak, A H ^a   Alper, M ^a   Annakaya, A N ^a   Erbas, M ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

Chemotherapeutic agent; Docetaxel; Persistent serpentine supravenous hyperpigmented eruption; Supravenous discoloration

Indexed keywords

CISPLATIN; DOCETAXEL; GEMCITABINE; SODIUM CHLORIDE;

ADULT; ARM; ARTICLE; CASE REPORT; CELL DEATH; CHILL; DISEASE ASSOCIATION; DRUG ERUPTION; DRUG INFUSION; ERYTHEMA; FEVER; FOREARM; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERKERATOSIS; HYPERPIGMENTATION; INJECTION SITE REACTION; KERATINOCYTE; LUNG CARCINOMA; LYMPHADENOPATHY; MALE; PRIORITY JOURNAL; PRURITUS; PUNCH BIOPSY; SKIN ATROPHY; SKIN BLOOD VESSEL; SKIN DISCOLORATION; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ARM; CARCINOMA, SQUAMOUS CELL; DRUG ERUPTIONS; HUMANS; HYPERPIGMENTATION; LUNG NEOPLASMS; MALE; MIDDLE AGED; TAXOIDS; VEINS;

EID: 18844444218     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2005.01088.x     Document Type: Article

References (14)

1. Susser WS, Whitaker-Worth DL, Grant-Kels JM. Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 1999; 40: 367-398.
2. Pujol RM, Rocamora V, Lopez-Pousa A et al. Persistent supravenous erythematous eruption: a rare local complication of intravenous 5-fluorouracil therapy. J Am Acad Dermatol 1998; 39: 839-842.
3. Marcoux D, Anex R, Russo P. Persistent serpentine supravenous hyperpigmented eruption as an adverse reaction to chemotherapy combining actinomycin and vincristine. J Am Acad Dermatol 2000; 43: 540-546.
4. Vukelja SJ, Bonner MW, McCollough M et al. Unusual serpentine hyperpigmentation associated with 5-fluorouracil. J Am Acad Dermatol 1991; 25: 905-908.
5. Baselga E, Drolet BA, Casper J et al. Chemotherapy-associated supravenous hyperpigmentation. Dermatology 1996; 192: 384-385.
6. Cecchi R, Tuci F, Giomi A et al. Supravenous hyperpigmentation induced by vinorelbine. Dermatology 1994; 188: 244.
7. Ettinger DS. New drugs for treating small cell lung cancer. Lung Cancer 1995; 12: 53.
8. Hande KR. Chemotherapy. In: Pass, HI, Mitchell JB, Johnson DH et al., eds. Lung Cancer, 2nd edn. Williams & Wilkins, Philadelphia, 2000: 270-285.
9. Koehn GG, Balizet LB. Unusual local cutaneous reaction to dacarbazine. Arch Dermatol 1982; 118: 1018-1019.
10. Fine JD, Breathnach SM. Distinctive eruption characterized by linear supravenous papules and erythroderma following broxuridine (bromodeoxyuridine) therapy and radiotherapy. Arch Dermatol 1986; 122: 199-200.
11. Spencer HJ. Local erythema multiforme-like drug reaction following intravenous mitomycin C and 5-fluorouracil. J Surg Oncol 1984; 26: 47-50.
12. Schrijvers D, Van Den Brande J, Vermorken JB. Supravenous discoloration of the skin due to docetaxel treatment. Br J Dermatol 2000; 142: 1069-1070.
13. Jawitz JC, Albert MK, Nigra TP et al. A new skin manifestation of progressive systemic sclerosis. J Am Acad Dermatol 1984; 11: 265-268.
14. Werth VP, Schumacher HR, Von Feldt JM. Linear hyperpigmentation overlying veins in association with collagen vascular disease. J Am Acad Dermatol 1993; 29: 1039-1040.